Company
PROKIDNEY CORP. (PROK)
Standardized SEC financial data for PROKIDNEY CORP. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001850270 · NASDAQ · Biological Products, (No Diagnostic Substances).
Revenue growth (YoY)
1075.0%
Return on equity
6.8%
Free cash flow
-$135.3M
Current ratio
9.13×
EPS (diluted)
$-0.23
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $0 | $0 | $76K | $893K |
| R&D expense |
Balance sheet
| USD | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | $20.6M | $490.3M | $60.6M | $99.1M | $108.5M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$25.2M | -$50.3M | -$77.1M | -$90.1M | -$126.4M | -$120.1M |
| Capital expenditures |
Get PROK data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/PROK/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/PROK/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"